A549 cells infected with RSV Analysis Results (GEO series: GSE147507)
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 2.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.6 | 2.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.4 | 1.5 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.2 | 1.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.2 | 1.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 1.2 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.0 | 1.1 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.3 | 1.0 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.1 | 1.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 1.0 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.0 | 2.2 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 1.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 1.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.8 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 0.7 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.0 | 0.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.6 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.0 | 2.3 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 1.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 1.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 1.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 1.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 1.2 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 1.1 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 1.0 | GO:0015643 | toxic substance binding(GO:0015643) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.8 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 2.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 1.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.6 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |